Status:
COMPLETED
Early Injection of Botulinum Toxin on Motor Function and Gait Pattern in Stroke Patients
Lead Sponsor:
Changhua Christian Hospital
Conditions:
Stroke
Spasticity
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
Spasticity, muscle weakness, abnormal gait pattern are co-morbidities commonly seen in stroke patients. They cause disabled condition of patients in activities of daily life and functional performance...
Eligibility Criteria
Inclusion
- first-ever stroke, with spasticity within 3-months (MAS=2\~3)
- independent walking 10 meters (with assistive devices)
Exclusion
- recurrent stroke, cognition impaired
- lower limb fracture
- received anti-spasticity injection in the past
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01817816
Start Date
January 1 2009
End Date
June 1 2015
Last Update
November 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhua Christian Hospital
Dawan, Changhua, Taiwan, 500